Letter from the Editor - February 2012

Published 01 February 2012

FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST

Did you find this article relevant? Subscribe to UroToday-GUOncToday!

The fields of GU Oncology and Urology are advancing rapidly including new
treatments, enrolling clinical trials, screening and surveillance
recommendations along with updated guidelines. Join us as one of our
subscribers who rely on UroToday as their must-read source for the
latest news and data on drugs. Sign up today for blogs, video
conversations, conference highlights and abstracts from peer-review
publications by disease and condition delivered to your inbox and read
on the go.

Welcome to our first issue of 2012. UroToday International Journal has come a long way, and though there have been various changes, we remain a truly unique publication with a global reach. It’s a new year, but our formula is still the same—provide informative articles written by a broad spectrum of investigators from all over the globe. Thanks to our free manuscript submission and peer review, there is more to come, and we look forward to sharing all of the new and exciting content 2012 will offer to our worldwide readership.

Drake et al. present a thorough review of lower urinary tract dysfunction and its management in patients with neurological disease. They suggest a multidisciplinary approach, through various assessments and treatments, to achieve full rehabilitation and support.

Sherif et al. evaluate the technical aspects, success rates, and the complications of percutaneous nephrolithotomy in the supine position. Using ultrasound-guided renal puncture, they demonstrate a feasible, safe, and successful operation technique, with minimal complications

There is continued intensive research involving overactive bladder; however, Ho et al. argue that documentation of OAB in the Malaysian community has been neglected. Their study sheds light on the high prevalence of OAB, warranting close attention to the issue and an outline of preemptive measures.

Although epidemiological studies of penile cancer in Brazil are rare, de Andrade et al. discuss the highly affected male population, assessing various risk factors, such as socioeconomic status, access to medical care, and hygiene.

Siami et al. investigate dutasteride therapy with as-needed tamsulosin in the prevention of further lower urinary tract symptoms in patients with benign prostatic hyperplasia. Their research demonstrates little or no deterioration in the final 12 months of study.

We also present a series of case studies that include various topics, including psuedotumor of the urachus, Mondor’s disease of the penis, and Wilms tumor.

I offer my sincere thanks to our dedicated authors and readers, and to all of the reviewers who share their expertise and assist us in publishing this journal. We look forward to another successful and productive year.